Ralph Lauren Corp:企業の戦略・SWOT・財務分析

◆英語タイトル:Ralph Lauren Corp - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY5305
◆発行会社(調査会社):MarketLine
◆発行日:2020年3月
◆ページ数:45
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Retailing
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Ralph Lauren Corp – Strategy, SWOT and Corporate Finance Report
Summary

Ralph Lauren Corp – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Ralph Lauren Corporation (Ralph Lauren) operates in-stores, and online retail stores. It designs, markets and distributes premium lifestyle products in various international markets. The company’s product portfolio includes t-shirts and sweat shirts, casual shirts, sweaters, shorts and swimwear, underwear and loungewear, blazers and vests, skirts, and sleepwear. It also offers hats, scarves and gloves, bags and leather goods, belts and braces, socks, ties and pocket squares, sunglasses, cuff links, jewelry, diaper bags, blankets and swaddles, stuffed animals and plush toys, casual shoes, boots, sandals and sneakers. Ralph Lauren offers its products under various brands including Chaps, Club Monaco, Lauren, Pink Pony, Polo, Purple Label, Ralph Lauren, RRL, RLX, Rugby, Lauren Ralph Lauren and Ralph. It also offers gift cards, delivery services and hospitality services. Ralph Lauren is headquartered in New York City, New York, the US.

Scope

- Detailed information on Ralph Lauren Corp required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Ralph Lauren Corp in the form of a SWOT analysis
- An in-depth view of the business model of Ralph Lauren Corp including a breakdown and examination of key business segments
- Intelligence on Ralph Lauren Corp’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Ralph Lauren Corp, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to Buy

- Gain understanding of Ralph Lauren Corp and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Ralph Lauren Corp as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Ralph Lauren Corp’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Ralph Lauren Corp: Company Overview
Ralph Lauren Corp: Overview and Key Facts
Ralph Lauren Corp: Overview
Ralph Lauren Corp: Key Facts
Ralph Lauren Corp: Key Employees
Ralph Lauren Corp: Key Employee Biographies
Ralph Lauren Corp: Major Products and Services
Ralph Lauren Corp: Company History
Ralph Lauren Corp: Management Statement
Ralph Lauren Corp: Locations and Subsidiaries
Ralph Lauren Corp: Key Competitors
Ralph Lauren Corp: Company Analysis
Ralph Lauren Corp: Business Description
Ralph Lauren Corp: SWOT Analysis
Ralph Lauren Corp: SWOT Overview
Ralph Lauren Corp: Strengths
Ralph Lauren Corp: Weaknesses
Ralph Lauren Corp: Opportunities
Ralph Lauren Corp: Threats
Ralph Lauren Corp: Corporate Financial Deals Activity
Ralph Lauren Corp: Financial Deals Overview
Ralph Lauren Corp: Top Deals 2016 – 2020YTD*
Ralph Lauren Corp: Advisors
Ralph Lauren Corp: Top Legal Advisors
Ralph Lauren Corp: Top Financial Advisors
Ralph Lauren Corp: Capital Raising
Ralph Lauren Corp: Recent Developments
Ralph Lauren Corp: News and Events Summary
Ralph Lauren Corp: Business Expansion
Ralph Lauren Corp: Corporate Social Responsibility
Ralph Lauren Corp: Financial Performance
Ralph Lauren Corp: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Ralph Lauren Corp: Key Facts
Table 2: Ralph Lauren Corp: Key Employees
Table 3: Ralph Lauren Corp: Company History
Table 4: Ralph Lauren Corp: Locations and Subsidiaries
Table 5: Ralph Lauren Corp: Key Competitors
Table 6: Ralph Lauren Corp: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 7: Ralph Lauren Corp: Top Deals 2016 - 2020YTD*
Table 8: Ralph Lauren Corp: Legal Advisor Ranking by Value (US$m)
Table 9: Ralph Lauren Corp: Financial Advisor Ranking by Value (US$m)
Table 10: Ralph Lauren Corp: Capital Raising Volume and Value Trend (2016 - YTD*2020)
Table 11: Ralph Lauren Corp: Capital Raising by Deal Type (2016 - YTD*2020)
Table 12: Ralph Lauren Corp: News and Events Summary
Table 13: Ralph Lauren Corp: Business Expansion
Table 14: Ralph Lauren Corp: Corporate Social Responsibility
Table 15: Ralph Lauren Corp: Financial Performance
Table 16: Ralph Lauren Corp: Strategy and Operations

★海外企業調査レポート[Ralph Lauren Corp:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The Bank of Nova Scotia:企業のM&A・事業提携・投資動向
    The Bank of Nova Scotia - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's The Bank of Nova Scotia Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Immunicum AB (IMMU):製薬・医療:M&Aディール及び事業提携情報
    Summary Immunicum AB (Immunicum) is a biopharmaceutical company that focuses on the development of immuno-oncology therapies for the treatment of solid tumors. The company’s lead development candidate, ilixadencel is in clinical trials for the treatment a range of solid tumors including hepatic cell …
  • MacroGenics Inc (MGNX):製薬・医療:M&Aディール及び事業提携情報
    Summary MacroGenics Inc (MacroGenics) is a clinical-stage biopharmaceutical company which focuses on the discovery, development and delivery of novel antibody-based therapeutics for the treatment of cancer, infectious diseases and autoimmune disorders. Its pipeline includes product candidates for th …
  • Emerson Radio Corporation (MSN):企業の財務・戦略的SWOT分析
    Emerson Radio Corporation (MSN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Integrated BioPharma Inc (INBP):企業の財務・戦略的SWOT分析
    Summary Integrated BioPharma Inc (IBI) is a biopharmaceutical company that develops, manufactures and distributes vitamins, nutritional supplements and herbal products. The company’s contract business includes manufacturing, branded proprietary products, and other nutraceutical businesses. Its contr …
  • Polyus Gold International Limited:企業の戦略・SWOT・財務情報
    Polyus Gold International Limited - Strategy, SWOT and Corporate Finance Report Summary Polyus Gold International Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Hochdorf Holding AG (HOCN):企業の財務・戦略的SWOT分析
    Hochdorf Holding AG (HOCN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Luigi Lavazza S.p.A.:企業の戦略・SWOT・財務情報
    Luigi Lavazza S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Luigi Lavazza S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Aemetis Inc (AMTX):企業の財務・戦略的SWOT分析
    Summary Aemetis Inc (Aemetis) formerly AE Biofuels Inc is a renewable fuels and biochemicals company that produces advanced fuels and chemicals. The company’s products include biochemicals, renewable fuels, ethanol, ethanol co-products, glycerin, biodiesel, and edible oils, among others. It also pro …
  • NEC Networks & System Integration Corp (1973):企業の財務・戦略的SWOT分析
    NEC Networks & System Integration Corp (1973) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Triumph Group Inc:企業のM&A・事業提携・投資動向
    Triumph Group Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Triumph Group Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Alzinova AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Alzinova AB (Alzinova) is a pharmaceutical company that discovers and develops therapeutics for the treatment of Alzheimer’s disease. The company develops amyloid beta CC peptide technology, which offers long-term research and development capabilities including the discovery and development …
  • Diamond Offshore Drilling Inc (DOFSQ):企業の財務・戦略的SWOT分析
    Diamond Offshore Drilling Inc (DOFSQ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Skinvisible Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Skinvisible Pharmaceuticals Inc (Skinvisible Pharmaceuticals), a subsidiary of Skinvisible Inc is a pharmaceutical company that develops and manufactures prescription and over the counter dermatology, medical, cosmetic, consumer goods, and skincare products. The company’s products include an …
  • ZAPPALLAS, Inc. (3770):企業の財務・戦略的SWOT分析
    ZAPPALLAS, Inc. (3770) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Sanchez Energy Corp (SN):企業の財務・戦略的SWOT分析
    Summary Sanchez Energy Corp (Sanchez) is an independent exploration and production company that acquires and develops unconventional oil and natural gas resources. It operates in the horizontal development of resources from the Eagle Ford Shale in South Texas. The company also holds an undeveloped a …
  • Essar Power Ltd:企業の戦略的SWOT分析
    Essar Power Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • China Resources Zizhu Pharmaceutical Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary China Resources Zizhu Pharmaceutical Co Ltd (Zizhu Pharmaceutical) is a provider of pharmaceutical development, manufacture, and marketing programs. The company offers dietary supplements, women healthcare products, ophthalmology medicines, APIs and intermediates, anesthetic, biological agen …
  • ThromboGenics NV (THR)-製薬・医療分野:企業M&A・提携分析
    Summary ThromboGenics NV (ThromboGenics) is a biotechnology company, which develops and commercializes ophthalmic and cancer medicines. The company’s ocriplasmin, a recombinant derivative of the plasmin protein, is commercialized as Jetrea in the US to treat symptomatic vitreomacular adhesion (VMA) …
  • Insys Therapeutics Inc (INSY)-製薬・医療分野:企業M&A・提携分析
    Summary Insys Therapeutics Inc (Insys) is a specialty pharmaceutical company, which discovers, develops and commercializes novel drug delivery systems. The company’s flagship product, Subsys is a sublingual fentanyl spray for breakthrough cancer pain (BTCP) in opioid-tolerant patients. Its lead prod …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆